Efficacy and Safety of Tension-Free Vaginal Tape-Secur Mini-Sling Versus Standard Midurethral Slings for Female Stress Urinary Incontinence: A Systematic Review and Meta-Analysis.
10.5213/inj.2015.19.4.246
- Author:
Wei HUANG
1
;
Tao WANG
;
Huantao ZONG
;
Yong ZHANG
Author Information
1. Urology Department, Beijing Tian Tan Hospital, Capital Medical University, Beijing, China. doctorzhy@126.com
- Publication Type:Meta-Analysis ; Randomized Controlled Trial ; Original Article
- Keywords:
Urinary Incontinence, Stress;
Suburethral Slings;
Randomized Controlled Trial
- MeSH:
Female*;
Humans;
Intraoperative Complications;
Operative Time;
Postoperative Complications;
Suburethral Slings*;
Urinary Incontinence*;
Urinary Incontinence, Stress
- From:International Neurourology Journal
2015;19(4):246-258
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To assess the efficacy and safety of tension-free vaginal tape (TVT)-Secur for stress urinary incontinence (SUI). METHODS: A literature review was performed to identify all published trials of TVT-Secur. The search included the following databases: MEDLINE, Embase, and the Cochrane Controlled Trial Register. RESULTS: Seventeen publications involving a total of 1,879 patients were used to compare TVT-Secur with tension-free obturator tape (TVT-O) and TVT. We found that TVT-Secur had significant reductions in operative time, visual analog score for pain, and postoperative complications compared with TVT-O. Even though TVT-Secur had a significantly lower subjective cure rate (P<0.00001), lower objective cure rate (P<0.00001), and higher intraoperative complication rate, compared with TVT-O at 1 to 3 years, there was no significant difference between TVT-Secur and TVT-O in the subjective cure rate (odds ratio [OR], 0.49; 95% confidence interval [CI], 0.22-1.08; P=0.08), objective cure rate (OR, 0.49; 95% CI, 0.22-1.09; P=0.08), or complications at 3 to 5 years. Moreover, TVT-Secur had significantly lower subjective and objective cure rates compared with TVT. CONCLUSIONS: This meta-analysis indicates that TVT-Secur did not show an inferior efficacy and safety compared with TVT-O for SUI in 3 to 5 years, even though displaying a clear tread toward a lower efficacy in 1 to 3 years. Considering that the safety is similar, there are no advantages in using TVT-Secur.
